000			01938 a2200553 4500
005			20250515122053.0
264		0	_c20080612
008			200806s 0 0 eng d
022			_a1555-7162
024	7		_a10.1016/j.amjmed.2008.02.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aGreenberg, Jeffrey D
245	0	0	_aTumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort. _h[electronic resource]
260			_bThe American journal of medicine _cJun 2008
300			_a532-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdalimumab
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aEtanercept
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aPatient Selection
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Tumor Necrosis Factor _xtherapeutic use
650	0	4	_aReproduction
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aUnited States
700	1		_aKishimoto, Mitsumasa
700	1		_aStrand, Vibeke
700	1		_aCohen, Stanley B
700	1		_aOlenginski, Thomas P
700	1		_aHarrington, Thomas
700	1		_aKafka, Shelly P
700	1		_aReed, George
700	1		_aKremer, Joel M
773	0		_tThe American journal of medicine _gvol. 121 _gno. 6 _gp. 532-8
856	4	0	_uhttps://doi.org/10.1016/j.amjmed.2008.02.018 _zAvailable from publisher's website
999			_c17994828 _d17994828